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Although invasive coronary angiography traditionally has been considered the reference standard for diagnosing coronary artery disease, its limitations are being highlighted with increasing frequency.
1 This is particularly evident in patients with intermediate or moderate coronary artery lesions. For this subset of narrowings, a number of adjunctive, invasive techniques have been proposed to improve the diagnostic accuracy of the coronary angiogram.
In landmark work by Lance Gould and colleagues, coronary flow reserve (CFR) defined as hyperemic coronary flow divided by resting coronary flow, was first proposed as a method for evaluating the functional significance of intermediate stenoses. 2 However, CFR by definition interrogates the status of the entire coronary circulation, both the epicardial vessel and the microcirculation. In patients with microvascular dysfunction, for example from diabetes or a past myocardial infarction, CFR will be abnormal, thus limiting its application for identifying ischemia-producing epicardial disease. CFR is also limited by its lack of a normal value in any given patient or vessel. FFR has a normal value of 1.0 in every patient and every vessel. It has a narrow ischemic threshold of 0.75-0.80, below which the potential for significant myocardial ischemia is extremely high and above which it is very unlikely. Because the measurement is made during maximal hyperemia, the effect of changes in resting hemodynamics is eliminated. 3, 4 FFR assumes that microvascular resistance is minimized during maximal hyperemia and constant in the presence and hypothetical absence of the stenosis; therefore, FFR is a specific measure of the contribution of the epicardial stenosis to the potential for myocardial ischemia and independent of the microvasculature. FFR informs the operator about the expected gain in myocardial flow should the epicardial stenosis be relieved. For these reasons, FFR has become a very useful technique for identifying which epicardial lesions are responsible for producing myocardial ischemia, which are more likely to cause future cardiac events, and which are therefore most likely to result in a benefit for the patient if revascularized. 11, 12, 13 A nonischemic FFR value in a particular vessel rules out significant epicardial atherosclerosis, but it does not rule out the potential for ischemia occurring in the microvasculature.
For many years it has been recognized that myocardial ischemia can result from other coronary circulatory pathology beyond epicardial artery stenosis. One of these mechanisms is microvascular dysfunction. To address the limitations of CFR and to complement FFR's ability to assess the epicardial vessel, ten years ago the index of microcirculatory resistance (IMR) was introduced as a method specifically for evaluating the microvasculature. 14 IMR is measured at the same time as FFR, with the same coronary pressure wire. With appropriate software, the pressure sensor acts as a distal thermistor and the shaft of the wire acts as a proximal thermistor allowing the calculation of the mean transit time of injected room temperature saline, which is inversely proportional to coronary flow. IMR is calculated by dividing distal coronary pressure by the inverse of the mean transit time during maximal hyperemia and represents the minimal achievable resistance in a particular myocardial territory. It correlates well with true microvascular resistance; 14 it is reproducible and independent of hemodynamic perturbations; 4 it is specific for the microvasculature and not affected by epicardial stenosis (as long as collateral flow is accounted for); 15, 16 and it has been found to be predictive of adverse outcomes in disease states affecting the microvasculature, such as acute myocardial infarction. important to note that the population studied had a high rate of predisposing factors (54% with previous myocardial infarction, 73% with hypertension, 69% with dyslipidemia and 26% with diabetes).
Another finding in this study was that an abnormal FFR, indicative of significant epicardial disease, did not imply abnormal microvascular function, as most of these vessels had a normal IMR. This is not too surprising given that the authors only studied intermediate coronary by a recent prospective, randomized study including patients with focal disease and low FFR who did benefit from revascularization. 13 In the group of patients with a high FFR and low CFR, the authors attribute the findings to both diffuse epicardial atherosclerosis and microvascular dysfunction. Clearly patients with pure microvascular dysfunction will fall into this category, and indeed an abnormal IMR was found in many of these patients. However, some vessels did have a normal IMR, abnormal CFR and normal FFR. If diffuse atherosclerosis was the culprit, one would expect FFR to be abnormal as well. One of the advantages of FFR is that it interrogates the entire epicardial vessel and mild diffuse atherosclerosis, which is not visible angiographically can still result in an abnormal FFR. 20 Another explanation for the abnormal CFR despite the normal FFR and normal IMR relates to the dependence of the CFR calculation on resting flow. The authors found a significantly higher "resting" coronary flow (shorter mean transit time) in this cohort compared to the cohort with a high FFR and high CFR, while the hyperemic flow was similar; the higher "resting" flow, which can result from changes in heart rate, blood pressure and left ventricular contractility leads to the lower CFR, which may not be a reflection of pathology, but a limitation of the measurement.
In summary, when invasively assessing intermediate coronary disease, there is more to it than meets the eye; visual interpretation of the coronary angiogram is insufficient. Determining FFR provides information regarding the contribution of epicardial coronary disease to myocardial ischemia, while IMR and other measures of microvascular function provide further insight, particularly when FFR is in the nonischemic range.
